Literature DB >> 31533988

A GLIS3-CD133-WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids.

Jacob R Tremblay1,2, Kassandra Lopez1, Hsun Teresa Ku3,2.   

Abstract

The existence and regenerative potential of resident stem and progenitor cells in the adult pancreas are controversial topics. A question that has been only minimally addressed is the capacity of a progenitor cell to self-renew, a key attribute that defines stem cells. Previously, our laboratory has identified putative stem and progenitor cells from the adult murine pancreas. Using an ex vivo colony/organoid culture system, we demonstrated that these stem/progenitor-like cells have self-renewal and multilineage differentiation potential. We have named these cells pancreatic colony-forming units (PCFUs) because they can give rise to three-dimensional colonies. However, the molecular mechanisms by which PCFUs self-renew have remained largely unknown. Here, we tested the hypothesis that PCFU self-renewal requires GLIS family zinc finger 3 (GLIS3), a zinc-finger transcription factor important in pancreas development. Pancreata from 2- to 4-month-old mice were dissociated, sorted for CD133highCD71low ductal cells, known to be enriched for PCFUs, and virally transduced with shRNAs to knock down GLIS3 and other proteins. We then plated these cells into our colony assays and analyzed the resulting colonies for protein and gene expression. Our results revealed a previously unknown GLIS3-to-CD133-to-WNT signaling axis in which GLIS3 and CD133 act as factors necessary for maintaining WNT receptors and signaling molecules in colonies, allowing responses to WNT ligands. Additionally, we found that CD133, but not GLIS3 or WNT, is required for phosphoinositide 3-kinase (PI3K)/AKT Ser/Thr kinase (AKT)-mediated PCFU survival. Collectively, our results uncover a molecular pathway that maintains self-renewal of adult murine PCFUs.
© 2019 Tremblay et al.

Entities:  

Keywords:  GLIS family zinc finger 3; Wnt signaling; cell replacement; cell therapy; endocrinology; pancreas; progenitor cell; self-renewal; stem cells; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31533988      PMCID: PMC6851293          DOI: 10.1074/jbc.RA118.002818

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

Review 1.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Authors:  T Hirano; K Ishihara; M Hibi
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

2.  XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.

Authors:  M Molenaar; M van de Wetering; M Oosterwegel; J Peterson-Maduro; S Godsave; V Korinek; J Roose; O Destrée; H Clevers
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Postnatal Pancreas of Mice Contains Tripotent Progenitors Capable of Giving Rise to Duct, Acinar, and Endocrine Cells In Vitro.

Authors:  Nadiah Ghazalli; Alborz Mahdavi; Tao Feng; Liang Jin; Mark T Kozlowski; Jasper Hsu; Arthur D Riggs; David A Tirrell; H Teresa Ku
Journal:  Stem Cells Dev       Date:  2015-06-09       Impact factor: 3.272

4.  Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Authors:  David B Ring; Kirk W Johnson; Erik J Henriksen; John M Nuss; Dane Goff; Tyson R Kinnick; Sylvia T Ma; John W Reeder; Isa Samuels; Trina Slabiak; Allan S Wagman; Mary-Ellen Wernette Hammond; Stephen D Harrison
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

5.  PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung.

Authors:  J Wang; T Ito; N Udaka; K Okudela; T Yazawa; H Kitamura
Journal:  Tissue Cell       Date:  2004-12-08       Impact factor: 2.466

6.  Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.

Authors:  Germana Rappa; Javier Mercapide; Fabio Anzanello; Thuc T Le; Mary G Johlfs; Ronald R Fiscus; Michaela Wilsch-Bräuninger; Denis Corbeil; Aurelio Lorico
Journal:  Exp Cell Res       Date:  2013-01-12       Impact factor: 3.905

7.  GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions.

Authors:  Yong-Sik Kim; Gen Nakanishi; Mark Lewandoski; Anton M Jetten
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

8.  Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.

Authors:  Felix H Brembeck; Thomas Schwarz-Romond; Jeroen Bakkers; Sabine Wilhelm; Matthias Hammerschmidt; Walter Birchmeier
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

9.  Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.

Authors:  Eleanor Y Chen; Michael T DeRan; Myron S Ignatius; Kathryn Brooke Grandinetti; Ryan Clagg; Karin M McCarthy; Riadh M Lobbardi; Jillian Brockmann; Charles Keller; Xu Wu; David M Langenau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

10.  Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells.

Authors:  Rocio Sancho; Ralph Gruber; Guoqiang Gu; Axel Behrens
Journal:  Cell Stem Cell       Date:  2014-08-07       Impact factor: 24.633

View more
  3 in total

Review 1.  GLIS1-3: Links to Primary Cilium, Reprogramming, Stem Cell Renewal, and Disease.

Authors:  Anton M Jetten; David W Scoville; Hong Soon Kang
Journal:  Cells       Date:  2022-06-03       Impact factor: 7.666

Review 2.  Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.

Authors:  David W Scoville; Hong Soon Kang; Anton M Jetten
Journal:  Pharmacol Ther       Date:  2020-07-18       Impact factor: 12.310

Review 3.  A pancreas tumor derived organoid study: from drug screen to precision medicine.

Authors:  Jia Yao; Man Yang; Lawrence Atteh; Pinyan Liu; Yongcui Mao; Wenbo Meng; Xun Li
Journal:  Cancer Cell Int       Date:  2021-07-27       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.